152 related articles for article (PubMed ID: 29768330)
1. Risk factors for osteoporosis in liver cirrhosis patients measured by transient elastography.
Zheng JP; Miao HX; Zheng SW; Liu WL; Chen CQ; Zhong HB; Li SF; Fang YP; Sun CH
Medicine (Baltimore); 2018 May; 97(20):e10645. PubMed ID: 29768330
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation.
Alcalde Vargas A; Pascasio Acevedo JM; Gutiérrez Domingo I; García Jiménez R; Sousa Martín JM; Ferrer Ríos MT; Sayago Mota M; Giráldez Gallego A; Gómez Bravo MA
Transplant Proc; 2012; 44(6):1496-8. PubMed ID: 22841194
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density loss in patients with cirrhosis.
Muhsen IN; AlFreihi O; Abaalkhail F; AlKhenizan A; Khan M; Eldali A; Alsohaibani F
Saudi J Gastroenterol; 2018; 24(6):342-347. PubMed ID: 29943736
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective study.
Mahmoudi A; Sellier N; Reboul-Marty J; Chalès G; Lalatonne Y; Bourcier V; Grando V; Barget N; Beaugrand M; Trinchet JC; Ganne-Carrié N
Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):731-7. PubMed ID: 21873139
[TBL] [Abstract][Full Text] [Related]
5. Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
Kim G; Kim KJ; Rhee Y; Lim SK
PLoS One; 2017; 12(7):e0182202. PubMed ID: 28759632
[TBL] [Abstract][Full Text] [Related]
6. Study of Correlation of Bone Mineral Density with Severity of Liver Cirrhosis.
Shukla V; Fatima J; Siddiqui Z; Kugashiya R; Islam ZU
J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355840
[TBL] [Abstract][Full Text] [Related]
7. NAFLD and Liver Fibrosis Are Not Associated With Reduced Femoral Bone Mineral Density in the General US Population.
Ciardullo S; Muraca E; Zerbini F; Manzoni G; Perseghin G
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2856-e2865. PubMed ID: 33878156
[TBL] [Abstract][Full Text] [Related]
8. Chronic kidney disease is associated with low BMD at the hip but not at the spine.
Bezerra de Carvalho KS; Vasco RFV; Custodio MR; Jorgetti V; Moysés RMA; Elias RM
Osteoporos Int; 2019 May; 30(5):1015-1023. PubMed ID: 30693381
[TBL] [Abstract][Full Text] [Related]
9. [A study of osteopenia in liver cirrhosis by dual energy X-ray absorptiometry (DXA)].
Nakano A; Kanda T; Miyamoto T; Ishigami Y; Sato T; Shimizu Y
Nihon Shokakibyo Gakkai Zasshi; 1993 Aug; 90(8):1689-94. PubMed ID: 8361060
[TBL] [Abstract][Full Text] [Related]
10. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.
Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martinez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
Calcif Tissue Int; 1997 Feb; 60(2):148-54. PubMed ID: 9056162
[TBL] [Abstract][Full Text] [Related]
11. Risk factors associated with hepatic osteopathy in HBV related cirrhosis measured by liver stiffness: An Observational study.
Zhang W; Gong H; Su Z; Zhang X; Cao S
Medicine (Baltimore); 2019 Aug; 98(31):e16628. PubMed ID: 31374030
[TBL] [Abstract][Full Text] [Related]
12. A System to Determine Risk of Osteoporosis in Patients With Autoimmune Hepatitis.
Schmidt T; Schmidt C; Strahl A; Mussawy H; Rolvien T; Jandl NM; Casar C; Oheim R; Schinke T; Lohse AW; Amling M; Schramm C; Barvencik F
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):226-233.e3. PubMed ID: 31163277
[TBL] [Abstract][Full Text] [Related]
13. RISK FACTORS ASSOCIATED WITH FRACTURE OF THE LUMBOSACRAL SPINE AND ITS COMPROMISE IN THE QUALITY OF LIFE OF CIRRHOTICS.
Siqueira MMLG; Casulari LA; Freitas WM; Carneiro MV; Mendes LSC
Arq Gastroenterol; 2022; 59(1):9-15. PubMed ID: 35442344
[TBL] [Abstract][Full Text] [Related]
14. Utility of DXA scanning and risk factors for osteoporosis in ankylosing spondylitis-A prospective study.
Magrey MN; Lewis S; Asim Khan M
Semin Arthritis Rheum; 2016 Aug; 46(1):88-94. PubMed ID: 27162010
[TBL] [Abstract][Full Text] [Related]
15. Screening for osteopenia and osteoporosis: selection by body composition.
Michaëlsson K; Bergström R; Mallmin H; Holmberg L; Wolk A; Ljunghall S
Osteoporos Int; 1996; 6(2):120-6. PubMed ID: 8704349
[TBL] [Abstract][Full Text] [Related]
16. Bone disease in patients with cirrhosis of different etiology and severity; are Klotho protein and osteoprotegerin potential biomarkers?
Katsaounis PV; Hadjiyannis ES; Skaltsi T; Anargyrou VA; Alexopoulou AA; Dourakis SP; Koskinas JS
Scand J Gastroenterol; 2023 Feb; 58(2):185-192. PubMed ID: 36028955
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis in cirrhotics before and after liver transplantation: relation with malnutrition and inflammatory status.
Huldén E; Castedal M; Karlsson MK; Kalaitzakis E; Swärd P
Scand J Gastroenterol; 2020 Mar; 55(3):354-361. PubMed ID: 32180479
[No Abstract] [Full Text] [Related]
18. Characterization of osteopenia/osteoporosis in adult scoliosis: does bone density affect surgical outcome?
Yagi M; King AB; Boachie-Adjei O
Spine (Phila Pa 1976); 2011 Sep; 36(20):1652-7. PubMed ID: 21304426
[TBL] [Abstract][Full Text] [Related]
19. A Correlation Analysis Between Adult Hepatic Fibrosis and Bone Mineral Density of the Lumbar Spine and Hip.
Chen C; Zhang R; Ren C; Wang Y
Altern Ther Health Med; 2024 Jan; 30(1):172-178. PubMed ID: 37773670
[TBL] [Abstract][Full Text] [Related]
20. Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients.
Zhang W; Li Y; Li S; Zhou J; Wang K; Li Z; Chen N; Chen X
Front Endocrinol (Lausanne); 2023; 14():1278505. PubMed ID: 38116314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
